Image Not FoundImage Not Found

AI

Elon Musk and Harvard’s David Sinclair Lead Breakthrough Gene Therapy Trials to Reverse Aging and Restore Vision

This briefing details the FDA-cleared ER-100 gene therapy trial using truncated Yamanaka factors for ocular age reprogramming, highlighting…

ByByOlivia Wilson Jan 31, 2026

OpenAI to Retire Controversial GPT-4o Chatbot by 2026 Amid Lawsuits Over User Mental Health and Safety Concerns

OpenAI’s retirement of GPT-4o by 2026 highlights AI safety challenges from engagement-driven model design, legal liabilities including wrongful-death…

ByByOlivia Wilson Jan 31, 2026

OpenAI Retires GPT-4o “Sycophantic” ChatGPT Model as Users Shift to Customizable GPT-5.2 with Enhanced Personality Features

OpenAI’s retirement of GPT-4o marks a shift from static LLMs to dynamic, programmable AI services with fine-grained customization,…

ByByKen Avery Jan 31, 2026

Elon Musk’s SpaceX IPO at $1.5T: Strategic xAI Merger, Orbital AI Data Centers & Pentagon AI Integration

Analysis of Elon Musk’s planned SpaceX IPO and xAI merger to create vertically integrated orbital AI data centers…

ByByLiam Brown Jan 31, 2026
Image Not Found

Why Traditional Internet Scammers Reject AI: Study Reveals Human Element Still Dominates Cybercrime Forums

This briefing analyzes generative AI adoption in cybercrime, revealing low-skill actors’ distrust and preference for manual, trust-based methods.…

ByByKen Avery May 8, 2026

Elon Musk’s Controversial Online Behavior: Deleted Tweets, Secret Accounts, and Social Media Manipulation Explored

Analysis of how a founder’s online behavior, amplified by platform algorithms, pseudonymous identities, and AI-mediated content like Grok,…

ByByMichael Smith May 8, 2026